REBOOT by itself showed no benefit to beta-blockers post-MI when EF >40% while suggesting a possible benefit in the EF 40-49% group, as reported by Borja Ibáñez, MD, PhD, of Centro Nacional de ...

"We believe that women need to be protected from the harms of chemical abortion drugs," said Amy O'Donnell, a spokesperson for Texas Alliance for Life, which supports the bill. "They harm women and ...

MADRID -- Extended low-dose apixaban (Eliquis) after venous thromboembolism (VTE) provoked by events like trauma or surgery in patients with obesity or other enduring risk factors dramatically reduced ...

Along with Director Susan Monarez, PhD, which other high-level official left the CDC this week? Jennifer Layden, MD, PhD, director of the Office of Public Health Data, Surveillance, and Technology ...

The phase III ODYSSEY-HCM trial was conducted in 22 countries and had participants with nonobstructive HCM randomized 1:1 to mavacamten or placebo for 48 weeks. The mavacamten group started at 5 mg ...

MADRID -- For uncontrolled or treatment-resistant hypertension, adding the novel aldosterone synthase inhibitor baxdrostat improved blood pressure in the randomized BaxHTN trial.

MADRID -- The high-dose inactivated influenza vaccine may reduce older people's risk of hospitalization for flu or pneumonia more than a standard-dose shot, according to two large open-label, ...

MADRID -- The novel oral cardiac myosin inhibitor aficamten improved exercise capacity and symptoms of obstructive hypertrophic cardiomyopathy (HCM) better than standard beta-blocker treatment, the ...

Parkinson's disease is not a natural consequence of aging; it is an unnatural one, maintain neurologists Ray Dorsey, MD, of Atria Health in New York City, and Michael Okun, MD, of the University of ...

State laws that allow clinicians to decide whether to start or maintain life-sustaining treatment vary widely in circumstances and requirements surrounding the decision making, according to a review ...

The FDA approved updated fall COVID vaccines this week with significant new restrictions; however, those criteria won't be the only barrier to access, since pharmacists' ability to vaccinate in some ...

The evisceration of the CDC is a disaster for all of us.